NCT07867522

Brief Summary

Bile leakage is a clinically important complication after liver resection in children and may require prolonged drainage, additional radiological or endoscopic procedures, or repeat surgery. The risk may be particularly high in patients with tumors adjacent to the hilar plate of the future liver remnant and tumors involving three adjoining liver sections. This prospective, single-center, open-label interventional study will enroll 12 children and adolescents aged 0 to 18 years who are undergoing liver resection and are considered to have a high risk of postoperative bile leakage. All participants will undergo prophylactic extrahepatic biliary drainage during liver resection. The study hypothesis is that prophylactic biliary drainage will reduce the incidence of bile leakage within 90 days after surgery compared with a prespecified historical cohort of high-risk patients treated at the same center. Participants will be followed for 90 days after liver resection. The primary outcome is the incidence of bile leakage during this period. Secondary outcomes include unsuccessful biliary drainage attempts, intraoperative complications, postoperative complications, and serious complications.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for not_applicable

Timeline
31mo left

Started Feb 2026

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress21%
Feb 2026May 2029

Study Start

First participant enrolled

February 10, 2026

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

October 5, 2026

Completed
4 days until next milestone

First Posted

Study publicly available on registry

October 9, 2026

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2029

Expected
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 2, 2029

Last Updated

October 9, 2026

Status Verified

October 1, 2026

Enrollment Period

3.2 years

First QC Date

October 5, 2026

Last Update Submit

October 5, 2026

Conditions

Keywords

Pediatric liver surgeryliver resectionhepatectomyposthepatectomy bile leakagebiliary fistulaprophylactic biliary drainagetranscystic biliary drainageexternal biliary drainagefocal liver lesionsliver tumorshilar platepostoperative complications

Outcome Measures

Primary Outcomes (1)

  • The null hypothesis is that the incidence of bile leakage is equal in the two groups

    To compare the incidence of postoperative bile leakage within 90 days after liver resection between the prospective group receiving prophylactic transcystic external biliary drainage and the prespecified historical high-risk control cohort.

    From the date of liver resection through postoperative day 90

Secondary Outcomes (5)

  • Unsuccessful prophylactic biliary drainage

    During the index liver resection

  • Intraoperative complications

    During the index liver resection

  • Severe intraoperative complications

    During the index liver resection

  • Postoperative complications

    : From the date of liver resection through postoperative day 90

  • Severe postoperative complications

    From the date of liver resection through postoperative day 90

Study Arms (1)

All participants will undergo prophylactic extrahepatic biliary drainage during liver resection.

EXPERIMENTAL
Procedure: prophylactic extrahepatic biliary drainage during liver resection

Interventions

This prospective, single-center, open-label interventional study will enroll 12 children and adolescents aged 0 to 18 years who are undergoing liver resection and are considered to have a high risk of postoperative bile leakage. All participants will undergo prophylactic extrahepatic biliary drainage during liver resection

All participants will undergo prophylactic extrahepatic biliary drainage during liver resection.

Eligibility Criteria

Age0 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Age from birth to 18 years, inclusive.
  • Presence of a focal liver lesion confirmed by laboratory and imaging findings.
  • Clinical indication for liver resection.
  • Involvement of three adjoining liver sections, corresponding to PRETEXT III-based anatomical extent.
  • Adjacency of the lesion to the hilar plate or Glissonean structures of the future liver remnant on contrast-enhanced computed tomography performed within 28 days before liver resection. Adjacency is defined as the absence of a visible tissue plane, including direct contact, compression, or radiological evidence of invasion.
  • Written informed consent provided by the participant's parent or legally authorized representative and assent from the participant, when applicable.

You may not qualify if:

  • Tumor invasion of the extrahepatic bile ducts.
  • Biliary drainage performed before the index liver resection.
  • Previous liver resection, such that the planned procedure would constitute a repeat liver resection.
  • Absence of an adequate contrast-enhanced computed tomography examination performed within 28 days before liver resection.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology

Moscow, Russia

RECRUITING

MeSH Terms

Conditions

Biliary FistulaCarcinoma, HepatocellularPostoperative Complications

Condition Hierarchy (Ancestors)

Digestive System FistulaDigestive System DiseasesFistulaPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsAdenocarcinomaCarcinomaNeoplasms, Glandular and EpithelialNeoplasms by Histologic TypeNeoplasmsLiver NeoplasmsDigestive System NeoplasmsNeoplasms by SiteLiver DiseasesPathologic Processes

Central Study Contacts

Dmitry G Akhaladze, MD, PHD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 5, 2026

First Posted

October 9, 2026

Study Start

February 10, 2026

Primary Completion (Estimated)

May 1, 2029

Study Completion (Estimated)

May 2, 2029

Last Updated

October 9, 2026

Record last verified: 2026-10

Locations